NASDAQ:AXSM Long Term Investor Alert: Investigation of Potential Wrongdoing at Axsome Therapeutics, Inc.

An investigation on behalf of current long term investors in Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

Logo

San Diego, CA -- (SBWire) -- 09/30/2022 --An investigation was announced for current long-term investors in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) concerning potential breaches of fiduciary duties by certain directors of Axsome Therapeutics, Inc..

Investors who are current long term investors in Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NASDAQ: AXSM stocks follows a lawsuit filed against Axsome Therapeutics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: AXSM stocks, concerns whether certain Axsome Therapeutics, Inc. directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose that Axsome's CMC practices were deficient with respect to AXS-07 and its manufacturing process, that as a result, Axsome was unlikely to submit the AXS-07 NDA on its initially represented timeline, that the foregoing CMC issues remained unresolved at the time that the FDA reviewed the AXS-07 NDA, that accordingly, the FDA was unlikely to approve the AXS-07 NDA, that as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Media Relations Contact

Christopher Clausen
Shareholders Foundation, Inc.
1-858-779-1554
https://www.shareholdersfoundation.com/

View this press release online at: http://rwire.com/1364329

ReleaseWire - 500 Error

Unfortunately, something has gone wrong.

We're unable to fulfill your request. Rest assured we have been notified and are looking into the issue. Please refresh your browser. If the error continues, please contact our support team.